HLS Therapeutics Inc
TSX:HLS

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
TSX:HLS
Watchlist
Price: 4.97 CAD 0.2% Market Closed
Market Cap: 157.2m CAD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
-10%
Revenue
Forecast
+2%
Operating Income
Forecast
-4%
Net Income
Forecast
+3%

Wall Street
Price Targets

HLS Price Targets Summary
HLS Therapeutics Inc

Wall Street analysts forecast HLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HLS is 5.74 CAD with a low forecast of 4.04 CAD and a high forecast of 9.45 CAD.

HLS Lowest Forecast
Wall Street Target
4.04 CAD
19% Downside
HLS Average Forecast
Wall Street Target
5.74 CAD
15% Upside
HLS Highest Forecast
Wall Street Target
9.45 CAD
90% Upside
Lowest
Price Target
4.04 CAD
19% Downside
Average
Price Target
5.74 CAD
15% Upside
Highest
Price Target
9.45 CAD
90% Upside
HLS Therapeutics Inc Competitors:
Price Targets
9729
Tokai Corp (Gifu)
7% Upside
FAGR
Fagron NV
5% Upside
AMP
Amplifon SpA
29% Upside
GALE
Galenica AG
0% Upside
9729
Tokai Corp (Gifu)
7% Upside
FAGR
Fagron NV
5% Upside
AMP
Amplifon SpA
29% Upside
GALE
Galenica AG
0% Upside
SELEC.E
Selcuk Ecza Deposu Ticaret ve Sanayi AS
1% Upside
U
UPR
Uniphar PLC
24% Upside
COR
Cencora Inc
9% Upside

Revenue
Forecast

Revenue Estimate
HLS Therapeutics Inc

The compound annual growth rate of HLS Therapeutics Inc's revenue for the next 3 years is 10%.

N/A
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
HLS Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
HLS Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat
What are analyst estimates?

See Also

Summary
HLS intrinsic value, competitors valuation, and company profile.
DCF Valuation
HLS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HLS stock valuation using valuation multiples.
Wall Street Estimates
HLS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HLS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HLS's stock price target?
Price Target
5.74 CAD

According to Wall Street analysts, the average 1-year price target for HLS is 5.74 CAD with a low forecast of 4.04 CAD and a high forecast of 9.45 CAD.

What is HLS Therapeutics Inc's Revenue forecast?
Projected CAGR
10%

The compound annual growth rate of HLS Therapeutics Inc's revenue for the next 3 years is 10%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 262,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.